[Skip to Content](https://www.sigmaaldrich.com#main-content)
[](https://www.sigmaaldrich.com/US/en)
Products
Cart0
USEN
Products
[Login / Register](https://www.sigmaaldrich.com/oidc-sign-in)
[Order Lookup](https://www.sigmaaldrich.com/US/en/order-lookup)
[Quick Order](https://www.sigmaaldrich.com/US/en/quick-order)
Cart0
[Home](https://www.sigmaaldrich.com/US/en)[Stem Cell Culture](https://www.sigmaaldrich.com/US/en/applications/cell-culture-and-cell-culture-analysis/cell-culture-by-cell-type/stem-cell-culture)Induced Pluripotent Stem Cell Differentiation Protocols
# Induced Pluripotent Stem Cell Differentiation Protocols
### Read about
- [What are Induced Pluripotent Stem Cells?](https://www.sigmaaldrich.com#what-are-ipscs)
- [iPSC Collection](https://www.sigmaaldrich.com#ipsc-collection)
- [Frequently Asked Questions about iPSCs](https://www.sigmaaldrich.com#faqs)
- [Related Products](https://www.sigmaaldrich.com#products)
- [References](https://www.sigmaaldrich.com#references)
## What are Induced Pluripotent Stem Cells?
Adult somatic cells can be reprogrammed into induced pluripotent [stem cells](https://www.sigmaaldrich.com/US/en/products/cell-culture-and-analysis/cell-lines-and-specialty-cell-culture/stem-cells) (iPSCs) with the overexpression of key reprogramming genes (OCT4, KLF4, SOX2, cMYC, NANOG and LIN28). Human iPSCs have the unique ability to differentiate into any cell type of the body including:
- __Ectodermal__: Neuron, Astrocyte, Oligodendrocyte, Retinal Epithelial Cell (RPE), Epidermal, Hair and Keratinocytes.
- __Endodermal__: Hepatocyte, Pancreatic β-islet Cell, Intestinal Epithelial Cell, Lung Alveolar Cells.
- __Mesodermal__: Hematopoietic, Endothelial Cell, Cardiomyocyte, Smooth Muscle Cell, Skeletal Muscle Cell, Renal cell, Adipocyte, Chondrocyte and Osteocytes.

__Figure 1.__iPSC Pathway
## iPSC Collection
We offer a large collection of cell culture media, supplements, bioactive small molecules, and growth factors used to control the cell fate of human iPSCs. The table below highlights the most widely used protocols, media and characterization antibodies used to differentiate human iPSCs into different cell lineages.
Differentiated Cell TypeMedia and SupplementsCharacterization AntibodiesReference
Neural Stem Cell[DMEM/F12](https://www.sigmaaldrich.com/US/en/product/SIGMA/d6421), [Glutamine,](https://www.sigmaaldrich.com/US/en/product/SIGMA/g6392) [Neurobasal Media](https://www.sigmaaldrich.com/US/en/product/SIGMA/n3100), [N2](https://www.sigmaaldrich.com/US/en/product/MM/scm012), [B27](https://www.sigmaaldrich.com/catalog/product/mm/scm013), [SB431542](https://www.sigmaaldrich.com/US/en/product/SIGMA/s4317), [CHIR99021](https://www.sigmaaldrich.com/US/en/product/SIGMA/sml1046), [Compound E](https://www.sigmaaldrich.com/US/en/product/MM/565790), [Human LIF](https://www.sigmaaldrich.com/US/en/product/SIGMA/l5283), [Noggin](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp4675), [bFGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/f0291), [EGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/e9644)
[Order Complete Media](https://www.sigmaaldrich.com/US/en/product/mm/scm110)Nestin, PAX6, OTX2Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling1
Cortical Neuron[DMEM/F12](https://www.sigmaaldrich.com/US/en/product/SIGMA/d6421), [Glutamine,](https://www.sigmaaldrich.com/US/en/product/SIGMA/g6392) [Neurobasal Media](https://www.sigmaaldrich.com/US/en/product/SIGMA/n3100), [N2](https://www.sigmaaldrich.com/US/en/product/MM/scm012), [B27](https://www.sigmaaldrich.com/catalog/product/mm/scm013), [SB431542](https://www.sigmaaldrich.com/US/en/product/SIGMA/s4317), [CHIR99021](https://www.sigmaaldrich.com/US/en/product/SIGMA/sml1046), [Compound E](https://www.sigmaaldrich.com/US/en/product/MM/565790), [Noggin](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp4675), [bFGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/f0291), [EGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/e9644)
[Order Complete Media](https://www.sigmaaldrich.com/US/en/product/mm/scm111)MAP2, TBR1, CTIP2, VGLUT1Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks2
Dopaminergic Neuron[DMEM/F12](https://www.sigmaaldrich.com/US/en/product/SIGMA/d6421), [Glutamine,](https://www.sigmaaldrich.com/US/en/product/SIGMA/g6392) [Neurobasal Media](https://www.sigmaaldrich.com/US/en/product/SIGMA/n3100), [N2](https://www.sigmaaldrich.com/US/en/product/MM/scm012), [B27](https://www.sigmaaldrich.com/catalog/product/mm/scm013), [SB431542](https://www.sigmaaldrich.com/US/en/product/SIGMA/s4317), [CHIR99021](https://www.sigmaaldrich.com/US/en/product/SIGMA/sml1046), [Compound E](https://www.sigmaaldrich.com/US/en/product/MM/565790), [Human LIF](https://www.sigmaaldrich.com/US/en/product/SIGMA/l5283), [SHH](https://www.sigmaaldrich.com/US/en/product/MM/gf174), [FGF8](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp4053), [BDNF](https://www.sigmaaldrich.com/US/en/product/SIGMA/b3795), [GDNF](https://www.sigmaaldrich.com/US/en/product/SIGMA/g1777), [TGFβ3](https://www.sigmaaldrich.com/US/en/product/SIGMA/t5425), [cAMP](https://www.sigmaaldrich.com/US/en/product/SIGMA/d0260)
[Order Complete Media](https://www.sigmaaldrich.com/US/en/product/mm/scr135)TH, TUJ-1, LMX1A, FOXA2, NURR1Directed differentiation of dopamine neurons from human pluripotent stem cells3
Motor Neurons[DMEM/F12](https://www.sigmaaldrich.com/US/en/product/SIGMA/d6421), [Glutamine,](https://www.sigmaaldrich.com/US/en/product/SIGMA/g6392) [Neurobasal Media](https://www.sigmaaldrich.com/US/en/product/SIGMA/n3100), [N2](https://www.sigmaaldrich.com/US/en/product/MM/scm012), [B27](https://www.sigmaaldrich.com/catalog/product/mm/scm013), [SB431542](https://www.sigmaaldrich.com/US/en/product/SIGMA/s4317), [CHIR99021](https://www.sigmaaldrich.com/US/en/product/SIGMA/sml1046), [Compound E](https://www.sigmaaldrich.com/US/en/product/MM/565790), [all-trans retinoic acid (ATRA)](https://www.sigmaaldrich.com/US/en/product/SIGMA/r2625), [SHH](https://www.sigmaaldrich.com/US/en/product/MM/gf174), [BDNF](https://www.sigmaaldrich.com/US/en/product/SIGMA/b3795), [CNTF](https://www.sigmaaldrich.com/US/en/product/SIGMA/c3710), [GDNF](https://www.sigmaaldrich.com/US/en/product/SIGMA/g1777)Nestin, TUJ-1, ChAT, Islet1, Hb9, Hoxa2Directed differentiation of human-induced pluripotent stem cells generates active motor neurons4
Astrocyte[DMEM/F12](https://www.sigmaaldrich.com/US/en/product/SIGMA/d6421), [Glutamine,](https://www.sigmaaldrich.com/US/en/product/SIGMA/g6392) [B27](https://www.sigmaaldrich.com/catalog/product/mm/scm013), [nonessential amino acids](https://www.sigmaaldrich.com/US/en/product/MM/tms001), [Penicillin-Streptomycin](https://www.sigmaaldrich.com/US/en/product/MM/tmsab2), [FBS](https://www.sigmaaldrich.com/US/en/product/MM/es009), [bFGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/f0291), [CNTF](https://www.sigmaaldrich.com/US/en/product/SIGMA/c3710), [BMP4](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3016), [Activin A](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3003), [Heregulin 1β](https://www.sigmaaldrich.com/US/en/product/SIGMA/h7660), [IGF-1](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3069)GFAP, TUJ-1, CD44Efficient Generation of Astrocytes from Human Pluripotent Stem Cells in Defined Conditions5
Oligodendrocyte[DMEM/F12](https://www.sigmaaldrich.com/US/en/product/SIGMA/d6421), [Glutamine,](https://www.sigmaaldrich.com/US/en/product/SIGMA/g6392) [Neurobasal Media](https://www.sigmaaldrich.com/US/en/product/SIGMA/n3100), [N2](https://www.sigmaaldrich.com/US/en/product/MM/scm012), [B27](https://www.sigmaaldrich.com/catalog/product/mm/scm013), [SB431542](https://www.sigmaaldrich.com/US/en/product/SIGMA/s4317), [CHIR99021](https://www.sigmaaldrich.com/US/en/product/SIGMA/sml1046), [Compound E](https://www.sigmaaldrich.com/US/en/product/MM/565790), [Human LIF](https://www.sigmaaldrich.com/US/en/product/SIGMA/l5283), [all-trans retinoic acid (ATRA)](https://www.sigmaaldrich.com/US/en/product/SIGMA/r2625), [SHH](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3156), [SAG](https://www.sigmaaldrich.com/US/en/product/SIGMA/sml1314), [PDGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp6296), [IGF-I](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3069), [NT3](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3128), [Insulin](https://www.sigmaaldrich.com/US/en/product/SIGMA/i9278), [T3](https://www.sigmaaldrich.com/US/en/product/SIGMA/t5516), [cAMP](https://www.sigmaaldrich.com/US/en/product/SIGMA/d0260)PAX6, OLIG2, NKX2.2, O4, SOX10, MBP, MAP2Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells6
Cardiomyocyte[RPMI 1640](https://www.sigmaaldrich.com/US/en/product/SIGMA/r8758), [B27](https://www.sigmaaldrich.com/catalog/product/mm/scm013), [rH-albumin](https://www.sigmaaldrich.com/US/en/product/SIGMA/a9731)[, L-ascorbic acid 2-phosphate](https://www.sigmaaldrich.com/US/en/product/SIGMA/49752), [Lactate](https://www.sigmaaldrich.com/US/en/product/SIGMA/l7022), [CHIR99021](https://www.sigmaaldrich.com/US/en/product/SIGMA/sml1046), [Wnt-C59](http://www.emdmillipore.com/US/en/product/Porcn-Inhibitor-II%2C-C59---CAS-1243243-89-1---Calbiochem,EMD_BIO-500496?ReferrerURL=https%3A%2F%2Fwww.google.com%2F&bd=1)TNNT2, α-SMA, α-Actinin, vWF, MLC2A, MLC2VChemically defined generation of human cardiomyocytes7
Skeletal Muscle[IMDM](https://www.sigmaaldrich.com/US/en/product/SIGMA/i3390), [FBS](https://www.sigmaaldrich.com/US/en/product/MM/es009), [Glutamine](https://www.sigmaaldrich.com/US/en/product/SIGMA/g6392), [Penicillin-Streptomycin](https://www.sigmaaldrich.com/US/en/product/MM/tmsab2), [nonessential amino acids](https://www.sigmaaldrich.com/US/en/product/MM/tms001), [2-mercaptoethanol](https://www.sigmaaldrich.com/US/en/product/MM/es007), [oleic acid](https://www.sigmaaldrich.com/US/en/product/SIGMA/o1383), [linoleic acid](https://www.sigmaaldrich.com/US/en/product/SIGMA/l1012), [iron sulfate](https://www.sigmaaldrich.com/US/en/product/SIGMA/f8633), [sodium ferric gluconate](https://www.sigmaaldrich.com/product/SIGMA/344427&Brand=ALDRICH), [Horse Serum](https://www.sigmaaldrich.com/US/en/product/SIGMA/h1270), [Y-27632](https://www.sigmaaldrich.com/US/en/product/SIGMA/y0503), [bFGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/f0291)CD13, CD31, CD56, CD44, CD45, CD49b, CD146, MyHCEfficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cells8
Vascular Endothelial/ Smooth Muscle[DMEM/F12](https://www.sigmaaldrich.com/US/en/product/SIGMA/d6421), [Glutamine,](https://www.sigmaaldrich.com/US/en/product/SIGMA/g6392) [Neurobasal Media](https://www.sigmaaldrich.com/US/en/product/SIGMA/n3100), [N2](https://www.sigmaaldrich.com/US/en/product/MM/scm012), [B27](https://www.sigmaaldrich.com/catalog/product/mm/scm013), [CHIR99021](https://www.sigmaaldrich.com/US/en/product/SIGMA/sml1046), [BIO](https://www.sigmaaldrich.com/US/en/product/MM/361550), [Y-27632](https://www.sigmaaldrich.com/US/en/product/SIGMA/y0503), [BMP4](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3016), [VEGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/v7259), [Forskolin](https://www.sigmaaldrich.com/US/en/product/SIGMA/f6886), [PDGF-BB](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp6296), [Activin A](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3003), [Heparin](https://www.sigmaaldrich.com/product/SIGMA/h3149&Brand=SIAL)CD31, CD144, vWF, I-CAM1, SMA, MyHC, VECAD, PECAMGeneration of vascular endothelial and smooth muscle cells from human pluripotent stem cells9
Hepatocyte[RPMI 1640](https://www.sigmaaldrich.com/US/en/product/SIGMA/r8758), [B27](https://www.sigmaaldrich.com/catalog/product/mm/scm013), [Activin A](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3003), [BMP4](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3016), [bFGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/f0291), [HGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/h1404), [Oncostatin M](https://www.sigmaaldrich.com/US/en/product/SIGMA/o9635)FOXA2, SOX17, GATA4, HNF4-α, AFP, ALBHighly Efficient Generation of Human Hepatocyte–like Cells from Induced Pluripotent Stem Cells10
Pancreatic β-cell[DMEM/F12](https://www.sigmaaldrich.com/US/en/product/SIGMA/d6421), [IMDM](https://www.sigmaaldrich.com/US/en/product/SIGMA/i3390), [bovine serum albumin](https://www.sigmaaldrich.com/US/en/product/SIGMA/a3311), [N2](https://www.sigmaaldrich.com/US/en/product/MM/scm012), [B27](https://www.sigmaaldrich.com/catalog/product/mm/scm013), [ITS](https://www.sigmaaldrich.com/US/en/product/SIGMA/i3146), [BMP4](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3016), [Activin A](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3003), [FGF7](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp6161), [Noggin](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp4675), [bFGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/f0291), [EGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/e9644), [nicotinamide](https://www.sigmaaldrich.com/US/en/product/SIGMA/n0636), [Exendin-4](https://www.sigmaaldrich.com/US/en/product/SIGMA/e7144), [all-trans retinoic acid (ATRA)](https://www.sigmaaldrich.com/US/en/product/SIGMA/r2625)PDX1, FOXA2, SOX9, HNF1β, c-peptide, Insulin, SomatostatinHighly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells11
Lung[DMEM/F12](https://www.sigmaaldrich.com/US/en/product/SIGMA/d6421), [Glutamine,](https://www.sigmaaldrich.com/US/en/product/SIGMA/g6392) [B27](https://www.sigmaaldrich.com/catalog/product/mm/scm013), [N2](https://www.sigmaaldrich.com/US/en/product/MM/scm012), [ascorbic acid](https://www.sigmaaldrich.com/US/en/product/SIGMA/a4403), [monothioglycerol](https://www.sigmaaldrich.com/US/en/product/SIGMA/m6145), [bovine serum albumin](https://www.sigmaaldrich.com/US/en/product/SIGMA/a3311), [Penicillin-Streptomycin](https://www.sigmaaldrich.com/US/en/product/MM/tmsab2), [Y-27632](https://www.sigmaaldrich.com/US/en/product/SIGMA/y0503), [Dorsomorphin](https://www.sigmaaldrich.com/US/en/product/SIGMA/p5499), [SB431542](https://www.sigmaaldrich.com/US/en/product/SIGMA/s4317), [IWP2](https://www.sigmaaldrich.com/US/en/product/SIGMA/i0536), [CHIR99021](https://www.sigmaaldrich.com/US/en/product/SIGMA/sml1046), [BMP4](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3016), [bFGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/f0291), [Activin A](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp3003), [FGF-10](https://www.sigmaaldrich.com/US/en/product/SIGMA/f8924), [FGF7](https://www.sigmaaldrich.com/US/en/product/SIGMA/srp6161), [EGF](https://www.sigmaaldrich.com/US/en/product/SIGMA/e9644), [all-all-trans retinoic acid (ATRA)](https://www.sigmaaldrich.com/US/en/product/SIGMA/r2625)FOXA2, SOX2, NKX2.1, p63Efficient generation of lung and airway epithelial cells from human pluripotent stem cells12
## Frequently Asked Questions about iPSCs
## 1. Where are the challenges with stem cell differentiation, especially with respect to iPSCs?
- __Efficiency and Reproducibility__: Despite advancements, directing iPSCs to differentiate into specific cell types can still be inconsistent. Improving the consistency and reliability of differentiation protocols is crucial for their broader application in research and clinical settings. Furthermore, different iPSC lines may exhibit varying efficiencies in differentiating into specific germ layers, with some iPSC lines showing enhanced differentiation towards mesoderm compared to endoderm, and vice versa.
- __Heterogeneity of Differentiated Cell Populations__: Even successful differentiation often results in heterogeneous cell populations with varying maturity, functionality, and purity. Controlling for and minimizing this heterogeneity is essential for obtaining uniform and functional cell populations for downstream applications.
- __Maturation and Functionality__: Achieving mature and functional iPSC-derived cells is challenging. Many cell types may exhibit immature phenotypes or functional deficiencies compared to native counterparts, so improving differentiation protocols is vital for enhancing clinical translation.
- __Scale-Up and Automation__: Scalable and automated differentiation platforms are needed to produce large quantities of consistent and high-quality cell products for clinical applications. Developing robust manufacturing processes to meet regulatory standards is crucial for commercialization.
## 2. How can scientists improve their stem cell differentiation results?
- __Optimize Culture Conditions__: Fine-tuning the culture medium composition, including growth factors, cytokines, small molecules, and supplements, can significantly influence the differentiation efficiency and specificity of stem cells. Iterative optimization of culture conditions based on systematic experimentation and feedback is essential for achieving reproducible and robust differentiation outcomes.
- __Use Defined and Chemically Defined Media__: Transitioning from complex and undefined culture systems to defined and chemically defined media formulations reduces variability and enhances the control over differentiation processes. Defined media formulations contain only well-characterized components facilitate standardization, scalability, and regulatory compliance, particularly for clinical applications.
- __Employ Biomimetic Culture Systems__: Mimicking the physiological microenvironment of cells by utilizing biomimetic culture systems, such as 3D scaffolds, organ-on-a-chip platforms, and co-culture systems, enhances the relevance and fidelity of *in vitro* differentiation models. These systems provide spatial cues, cell-cell interactions, and mechanical stimuli that better recapitulate tissue architecture and function, promoting more physiologically relevant differentiation outcomes.
You can also integrate multi-omics approaches, utilize single-cell analysis, employ genome editing for precision control, and implement machine learning and data integration to improve differentiation results.
## 3. What are the biggest mistakes you see researchers making with iPSC differentiation protocols?
While researchers continue to make significant progress in stem cell differentiation protocols, several common mistakes can hinder the success and reproducibility of their experiments, such as:
- __Lack of Optimization__: Failing to thoroughly optimize differentiation protocols for specific cell types and experimental conditions can lead to variable or inconsistent outcomes. Researchers may overlook the importance of systematically testing various culture conditions, including growth factors, cytokines, substrate properties, and culture duration, to identify the optimal conditions for robust and reproducible differentiation.
- __Inadequate Characterization__: Insufficient characterization of differentiated cell populations can obscure the heterogeneity, maturity, and functionality of the cells produced. Researchers may overlook the need for comprehensive phenotypic and functional analyses, including immunostaining, flow cytometry, gene expression profiling, and functional assays, to validate the identity and quality of differentiated cells.
- __Failure to Address Heterogeneity__: Ignoring or inadequately addressing the heterogeneity within differentiated cell populations can compromise the reliability and interpretability of experimental results. Researchers may overlook the importance of purifying or enriching specific cell subsets, such as using fluorescence-activated cell sorting (FACS) or magnetic cell sorting, to obtain homogeneous cell populations for downstream analyses or applications.
- __Poor Reproducibility__: Neglecting to document and standardize experimental procedures, reagent preparations, and cell handling protocols can impede reproducibility across different laboratories or experiments. Researchers may overlook the significance of maintaining detailed records, following standardized operating procedures, and sharing protocols and reagents with the scientific community to facilitate reproducibility and transparency.
- __Ignoring Quality Control Measures__: Underestimating the importance of quality control measures, such as monitoring cell viability, purity, and sterility throughout the differentiation process, can lead to experimental artifacts or contamination issues. Researchers may overlook the need for regular cell line authentication, mycoplasma testing, and endotoxin screening to ensure the integrity and safety of cell cultures.
- __Overreliance on 2D Culture Systems__: Relying solely on traditional 2D culture systems without considering the limitations of these platforms in recapitulating complex tissue architecture and microenvironmental cues can yield suboptimal differentiation outcomes. Researchers may overlook the advantages of employing 3D culture systems, organoid models, or microfluidic devices to better mimic *in vivo* tissue physiology and enhance differentiation efficiency and functionality.
- __Insufficient Data Analysis and Interpretation__: Inadequate data analysis and interpretation can lead to misinterpretation or oversimplification of complex experimental results. Researchers may overlook the importance of applying appropriate statistical methods, data visualization techniques, and computational tools to analyze high-dimensional datasets and extract meaningful insights from their experiments.
## 4. How can technology help with stem cell differentiation protocols and results?
Technology plays a pivotal role in advancing stem cell differentiation protocols and improving the outcomes of these experiments in several ways:
1. __High-Throughput Screening (HTS)__: Automated platforms equipped with robotics, liquid handling systems, and imaging devices enable high-throughput screening of large compound libraries or culture conditions to identify factors that promote or inhibit stem cell differentiation. HTS accelerates the discovery of novel small molecules, growth factors, or culture media formulations that enhance differentiation efficiency and specificity.
2. __Omics Technologies__: Advances in genomics, transcriptomics, proteomics, and metabolomics allow for comprehensive profiling of stem cells and their differentiated progeny at the molecular level. Integration of multi-omics data provides insights into the regulatory networks, signaling pathways, and key biomarkers associated with different stages of differentiation, guiding the optimization of differentiation protocols and the identification of novel targets for modulating cell fate decisions.
3. __Genome Editing Tools__: Precise genome editing technologies, such as CRISPR-Cas9, enable targeted manipulation of gene expression, epigenetic modifications, and signaling pathways involved in stem cell differentiation. Genome editing allows researchers to engineer stem cells with desired phenotypic traits, enhance differentiation efficiency, and model genetic diseases *in vitro*, facilitating the study of disease mechanisms and the development of personalized therapies.
## Related Products
Sorry, an unexpected error has occurred
Response not successful: Received status code 500
### References
1\.
Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. 2009. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 27(3):275-280. [https://doi.org/10.1038/nbt.1529](https://doi.org/10.1038/nbt.1529)
2\.
Shi Y, Kirwan P, Livesey FJ. 2012. Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat Protoc. 7(10):1836-1846. [https://doi.org/10.1038/nprot.2012.116](https://doi.org/10.1038/nprot.2012.116)
3\.
Ma L, Liu Y, Zhang S. 2011. Directed Differentiation of Dopamine Neurons from Human Pluripotent Stem Cells.411-418. [https://doi.org/10.1007/978-1-61779-201-4\_30](https://doi.org/10.1007/978-1-61779-201-4_30)
4\.
Karumbayaram S, Novitch BG, Patterson M, Umbach JA, Richter L, Lindgren A, Conway AE, Clark AT, Goldman SA, Plath K, et al. 2009. Directed Differentiation of Human-Induced Pluripotent Stem Cells Generates Active Motor Neurons. 27(4):806-811. [https://doi.org/10.1002/stem.31](https://doi.org/10.1002/stem.31)
5\.
Shaltouki A, Peng J, Liu Q, Rao MS, Zeng X. 2013. Efficient Generation of Astrocytes from Human Pluripotent Stem Cells in Defined Conditions. 31(5):941-952. [https://doi.org/10.1002/stem.1334](https://doi.org/10.1002/stem.1334)
6\.
Douvaras P, Wang J, Zimmer M, Hanchuk S, O’Bara M, Sadiq S, Sim F, Goldman J, Fossati V. 2014. Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells. Stem Cell Reports. 3(2):250-259. [https://doi.org/10.1016/j.stemcr.2014.06.012](https://doi.org/10.1016/j.stemcr.2014.06.012)
7\.
Burridge PW, Matsa E, Shukla P, Lin ZC, Churko JM, Ebert AD, Lan F, Diecke S, Huber B, Mordwinkin NM, et al. 2014. Chemically defined generation of human cardiomyocytes. Nat Methods. 11(8):855-860. [https://doi.org/10.1038/nmeth.2999](https://doi.org/10.1038/nmeth.2999)
8\.
Maffioletti SM, Gerli MFM, Ragazzi M, Dastidar S, Benedetti S, Loperfido M, VandenDriessche T, Chuah MK, Tedesco FS. 2015. Efficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cells. Nat Protoc. 10(7):941-958. [https://doi.org/10.1038/nprot.2015.057](https://doi.org/10.1038/nprot.2015.057)
9\.
Patsch C, Challet-Meylan L, Thoma EC, Urich E, Heckel T, O’Sullivan JF, Grainger SJ, Kapp FG, Sun L, Christensen K, et al. 2015. Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells. Nat Cell Biol. 17(8):994-1003. [https://doi.org/10.1038/ncb3205](https://doi.org/10.1038/ncb3205)
10\.
Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, North PE, Dalton S, Duncan SA. 2010. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology. 51(1):297-305. [https://doi.org/10.1002/hep.23354](https://doi.org/10.1002/hep.23354)
11\.
Zhang D, Jiang W, Liu M, Sui X, Yin X, Chen S, Shi Y, Deng H. 2009. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 19(4):429-438. [https://doi.org/10.1038/cr.2009.28](https://doi.org/10.1038/cr.2009.28)
12\.
Huang SXL, Islam MN, O'Neill J, Hu Z, Yang Y, Chen Y, Mumau M, Green MD, Vunjak-Novakovic G, Bhattacharya J, et al. 2014. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol. 32(1):84-91. [https://doi.org/10.1038/nbt.2754](https://doi.org/10.1038/nbt.2754)
__Related Articles__
- [Protocol Guide: Cortical GABAergic Neuron Monoculture](https://www.sigmaaldrich.com/US/en/technical-documents/protocol/cell-culture-and-cell-culture-analysis/stem-cell-culture/cortical-gabaergic-neuron-monoculture)
- [Protocol Guide: Functional Tri-Culture of iPSC-Derived Human Neurons, Astrocytes, and Microglia](https://www.sigmaaldrich.com/US/en/technical-documents/protocol/cell-culture-and-cell-culture-analysis/stem-cell-culture/functional-tri-culture-ipsc-derived-human-neurons-astrocytes-microglia)
- [3D Pluripotent Stem Cells: Culture & Differentiation](https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/cell-culture-and-cell-culture-analysis/3d-cell-culture/three-d-biomatrix-white-paper-three-d-pluripotent-stem-cells)
- [Hematopoietic Cytokines](https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/cell-culture-and-cell-culture-analysis/mammalian-cell-culture/hematopoietic-cytokines)
- [Water for Mammalian Cell Culture](https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/cell-culture-and-cell-culture-analysis/mammalian-cell-culture/water-mammalian-cell-culture)
- [Cancer Stem Cell Detection with AldeRed™ 588-A](https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/cell-culture-and-cell-culture-analysis/stem-cell-culture/aldered-aldh-cancer-stem-cell)
- [ECMatrix™ Laminin Substrates are Superior Xeno-free Extracellular Matrix Coatings for Feeder-free Human Pluripotent Stem Cell Cultures](https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/cell-culture-and-cell-culture-analysis/stem-cell-culture/ecmatrix-laminin-substrates)
- [Embryo Culture Media](https://www.sigmaaldrich.com/US/en/technical-documents/technical-article/cell-culture-and-cell-culture-analysis/stem-cell-culture/embryo-culture-media)
- [View More](https://www.sigmaaldrich.com/US/en/search/facet-search?focus=sitecontent&term=facet-search)
__Related Product Categories__
- [Stem Cells](https://www.sigmaaldrich.com/US/en/products/cell-culture-and-analysis/cell-lines-and-specialty-cell-culture/stem-cells)
- [Animal Component Free Cell Culture Reagents](https://www.sigmaaldrich.com/US/en/products/cell-culture-and-analysis/animal-component-free-cell-culture-reagents)
- [Classical Media & Buffers](https://www.sigmaaldrich.com/US/en/products/cell-culture-and-analysis/cell-culture-media-and-buffers/classical-media-and-buffers)
- [Fetal Bovine Serum (FBS)](https://www.sigmaaldrich.com/US/en/products/cell-culture-and-analysis/cell-culture-supplements-and-reagents/fbs)
- [Growth Factors and Cytokines](https://www.sigmaaldrich.com/US/en/products/cell-culture-and-analysis/cell-culture-supplements-and-reagents/growth-factors-and-cytokines)
- [Cell Health Analysis](https://www.sigmaaldrich.com/US/en/products/cell-culture-and-analysis/cell-analysis/cell-health-analysis)
- [Millicell® Cell Culture Inserts & Plates](https://www.sigmaaldrich.com/US/en/products/labware/cell-culture-and-cryogenics/millicell-cell-culture-inserts-and-plates)
- [Cell Culture Supplies](https://www.sigmaaldrich.com/US/en/products/labware/cell-culture-and-cryogenics/cell-culture-supplies)
Top
__Sign In To Continue__
To continue reading please sign in or create an account.
Sign In__Don't Have An Account?__Register
An unknown error has occured.
- English - EN
- Español - ES
[Learn More](https://www.sigmaaldrich.com)